Health Canada drug identification number

DIN 02381524 — MYLAN-EFAVIRENZ 600 MG

MYLAN-EFAVIRENZ is a tablet of Efavirenz marketed by MYLAN PHARMACEUTICALS ULC. The full Efavirenz monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02381524
Brand name
MYLAN-EFAVIRENZ
Active ingredient
Efavirenz
Strength
600 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
MYLAN PHARMACEUTICALS ULC
Health Canada status
MARKETED
Drug class
Non-nucleoside reverse transcriptase inhibitor (NNRTI) - antiretroviral agent

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Efavirenz products

DINBrandStrengthFormManufacturerStatus
02418428 AURO-EFAVIRENZ 600 MG TABLET AURO PHARMA INC MARKETED
02458233 JAMP-EFAVIRENZ 600 MG TABLET JAMP PHARMA CORPORATION DORMANT
02389762 TEVA-EFAVIRENZ 600 MG TABLET TEVA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.